<?xml version="1.0" encoding="UTF-8"?>
<ref id="B121-vaccines-08-00273">
 <label>121.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Pardi</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Hogan</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>Naradikian</surname>
    <given-names>M.S.</given-names>
   </name>
   <name>
    <surname>Parkhouse</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Cain</surname>
    <given-names>D.W.</given-names>
   </name>
   <name>
    <surname>Jones</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Moody</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Verkerke</surname>
    <given-names>H.P.</given-names>
   </name>
   <name>
    <surname>Myles</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Willis</surname>
    <given-names>E.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses</article-title>
  <source>J. Exp. Med.</source>
  <year>2018</year>
  <volume>215</volume>
  <fpage>1571</fpage>
  <lpage>1588</lpage>
  <pub-id pub-id-type="doi">10.1084/jem.20171450</pub-id>
  <pub-id pub-id-type="pmid">29739835</pub-id>
 </element-citation>
</ref>
